O'Neill Gilmore Neil 4
4 · Editas Medicine, Inc. · Filed Mar 27, 2025
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2025-03-08+828,000→ 828,000 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (828,000 underlying) - Award
Stock Option (right to buy)
2025-03-08+175,000→ 175,000 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.
- [F2]This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.